<sub id="pfpd9"><dfn id="pfpd9"></dfn></sub>

<address id="pfpd9"><var id="pfpd9"></var></address>
<sub id="pfpd9"><var id="pfpd9"></var></sub>

<thead id="pfpd9"><var id="pfpd9"><ins id="pfpd9"></ins></var></thead>

<address id="pfpd9"><listing id="pfpd9"></listing></address>

<sub id="pfpd9"><dfn id="pfpd9"></dfn></sub>

<sub id="pfpd9"><dfn id="pfpd9"></dfn></sub>

    <thead id="pfpd9"><var id="pfpd9"><output id="pfpd9"></output></var></thead><sub id="pfpd9"><var id="pfpd9"><ins id="pfpd9"></ins></var></sub><sub id="pfpd9"></sub>
    <address id="pfpd9"></address><address id="pfpd9"></address>

    <sub id="pfpd9"><dfn id="pfpd9"></dfn></sub>

      Our R&D Team

      Learn more about the backgrounds, scientific pursuits and personal interests of members of our R&D team. These individuals are committed to pursuing Bristol-Myers Squibb’s goal of discovering, developing and delivering transformational medicines to patients.
      Beatrice Anduze-Faris, M.D.

      Head of Global Clinical Compliance & Continuous Improvement, Global Clinical Operations

      Bryan (Bo) Barnhart, Ph.D.

      Senior Director, Immuno-Oncology, Discovery

      Michaela Bowden

      Director, Translational Biology

      Cynthia Brogdon, RN, Ph.D.

      Head, Oncology Portfolio Strategy, Oncology Medical

      Edgar Charles, M.D.

      Clinical Development Lead, pegylated FGF21

      Sharon Cload, Ph. D.

      Vice President, Molecular Discovery Technologies

      Binodh DeSilva, Ph.D.

      Head of Analytical and Bioanalytical Operations, Pharmaceutical Development

      Melissa Harris, B.Sc, PharmD

      Development Team lead for Fibrosis, Cardiovascular, Fibrosis & Immunoscience

      Evan Janovitz, DVM, Ph.D., DACVP

      Director of Pathology, Discovery Toxicology?

      Emma Lees, Ph.D.

      Vice President, & Site Head of R&D, Oncology Discovery, Cambridge, MA

      Michael May, Ph.D.

      Countrywide Medical Director, Germany,?Global Medical

      Michael C. Montalto, Ph.D.

      Vice President, Pathology & Clinical Biomarker Laboratories

      Ryan Moslin, Ph.D.

      Senior Research Investigator, Early Immunology Discovery

      Mike Quigley, Ph.D.

      Vice President,?Head of Oncology Discovery Biology and Site Head, Redwood City

      Joseph Szustakowski, Ph.D.

      Executive Director, Translational Bioinformatics

      Saurabh Saha, M.D., Ph.D.

      SVP, Global Head of Translational Medicine, Cambridge Site Head

      John Throup, BSc, Ph.D.

      Development Lead, Immunoscience R&D